This groundbreaking research, spearheaded by clinician-researchers at the UCLA Health Jonsson Comprehensive Cancer Center and the UCLA Palliative Care Research Center, sheds new light on the psychosocial dimensions of cancer care. Published recently in the prestigious journal Cancer, the study exposes that a substantial proportion of patients with advanced cancer who prefer symptom relief and comfort-oriented care perceive their medical treatment as primarily focused on life prolongation instead. This divergence accentuates the challenge of aligning clinical interventions with patients’ values and goals, a fundamental tenet of patient-centered oncology.

The investigators conducted a sophisticated post-hoc cross-sectional analysis leveraging baseline data from a multi-site clinical trial centered around advance care planning among diverse seriously ill patient populations. This rigorous analytical approach enabled comparison of responses from 1,100 patients, 231 of whom had advanced cancer, alongside individuals with other life-limiting illnesses including advanced heart failure, chronic obstructive pulmonary disease (COPD), end-stage renal disease, and end-stage liver disease. Such comparative insights are critical for disentangling disease-specific patterns in treatment goal discordance.

Intriguingly, the data reveal that approximately 37% of advanced cancer patients who favored comfort-centered care reported that their actual treatment emphasis was on extending life. In contrast, only about 19% of patients with other serious chronic conditions experienced this type of misalignment. These findings suggest a uniquely pronounced gap in goal-concordant care within the oncology realm, despite similar severity and mortality risk profiles across the diverse patient groups studied. The implications challenge existing assumptions that oncology teams consistently calibrate treatment plans to patient preferences.

Further analysis demonstrates that the overall preferences between cancer and non-cancer patient cohorts are broadly comparable: roughly one quarter desire life-extending interventions, whereas close to half prefer care focused on symptom management and comfort. Yet, the realized care many patients perceive diverges substantially. More than half of patients with advanced cancer perceive their care as life-prolonging, while a smaller proportion—just 19%—report receiving comfort-oriented treatment, compared with 28% in the non-cancer cohort. This discordance highlights potential systemic issues in delivering palliative and supportive care that respects patient autonomy.

The study also elucidates the complex interplay of patient age, baseline health status, and treatment aggressiveness. Younger advanced cancer patients, typically with better functional reserves, may be offered and accept more aggressive therapies, even when these options do not align neatly with stated care goals. Additionally, advances in oncology therapeutics blur the distinction between life prolongation and quality of life benefits, complicating shared decision-making processes. These nuances demand nuanced, ongoing communication strategies.

Dr. Manan Shah, the study’s lead author and a clinical instructor in hematology/oncology at UCLA, underscores the urgency of addressing this treatment-goal discordance. He emphasizes that while some divergence is understandable due to the inherent complexity of serious illness management, the high prevalence of misaligned care perceptions among cancer patients is both surprising and concerning. It signals a critical need to enhance the depth and quality of communication between clinicians and patients to ensure that treatment trajectories genuinely reflect patient values.

Complementing these insights, senior author Dr. Anne Walling, a professor of medicine at UCLA, elaborates on the intricate decision-making landscape in advanced cancer. She notes that novel cancer therapies often offer the dual promises of extending survival and ameliorating symptom burden, yet these benefits may come with trade-offs. High-quality communication is essential to convey these complexities effectively, allowing patients to make informed choices aligned with their personal goals and quality of life priorities.

The findings also carry significant implications for prognosis awareness and advance care planning. The research team advocates for oncology care teams to proactively engage patients early in their treatment journey in candid discussions about prognosis, treatment intents, and personal priorities. This iterative, patient-centered approach is vital to reconcile expectations and optimize therapeutic plans congruent with individual goals.

Of particular note, the study reports no significant difference in two-year survival rates comparing patients who perceived their care as life-extending versus those who viewed it as comfort-centered (24% versus 15% mortality, respectively). This outcome challenges the assumption that aggressive life-prolonging treatments unequivocally yield meaningful survival benefits and further highlights the importance of aligning care with quality-of-life considerations.

The research also raises a call to action for clinicians to nurture an environment where patients feel empowered to voice concerns when their care does not match their preferences. Dr. Shah stresses that physicians must be responsive and willing to recalibrate treatment strategies in accordance with patients’ evolving goals. Such dynamic communication and shared decision-making practices possess the transformative potential to enhance patient satisfaction and clinical outcomes.

Contributing to the robust multidisciplinary team behind this important study were noted experts including Neil Wenger, John Glaspy, Ron Hays, and Chi-Hong Tseng from UCLA, as well as Rebecca Sudore and colleagues from the University of California system. Their collaborative efforts elucidate critical gaps and opportunities in delivering compassionate, goal-concordant care in advanced illness.

In a broader context, these findings underscore systemic challenges that persist in integrating palliative care principles into oncology. Despite growing recognition of the importance of patient-centered outcomes and quality of life, the oncology community must intensify efforts to embed nuanced communication frameworks and shared-decision models within everyday clinical practice. Addressing these gaps is essential to fulfill the ethical imperative of honoring patient autonomy amid the complexity of advanced cancer care.

As oncology care continues to evolve with scientific advances, ensuring that treatment aligns with patient values must remain a paramount focus. This pivotal study not only illuminates a critical area of unmet need but also charts a path forward: fostering deeper, transparent, and ongoing dialogues that center on the unique goals and preferences of each patient. Only through such commitment can the promise of truly personalized cancer care be realized.

Subject of Research: Alignment of treatment goals with patient care preferences in advanced cancer patients.

Article Title: [Not specified in the provided content.]

News Publication Date: [Not specified in the provided content.]

Web References:

• UCLA Health Jonsson Comprehensive Cancer Center: https://www.uclahealth.org/cancer
• UCLA Palliative Care Research Center: https://www.uclahealth.org/departments/medicine/internal-medicine/research/research-programs/palliative-care-research-center
• Journal article DOI: http://dx.doi.org/10.1002/cncr.35976

References:

• Shah M. et al., “Treatment Goal Concordance in Advanced Cancer: A Cross-sectional Analysis,” Cancer, DOI: 10.1002/cncr.35976

Image Credits: [Not specified in the provided content.]

Keywords: Cancer research; Patient-centered care; Advanced cancer; Treatment goals; Palliative care; Communication in oncology; Shared decision-making.

The study focuses on a cohort of 1,099 adults diagnosed with advanced cancer or other serious illnesses, exploring the alignment between patient-reported care preferences and the intent of treatments administered. Notably, half of the 231 patients with advanced cancer expressed a preference for comfort-focused care, emphasizing quality of life and symptom relief rather than prolonged survival. However, over one third of these patients reported receiving treatments aimed at extending life, despite their stated goals. This phenomenon, termed “discordant care,” poses significant clinical and moral dilemmas by potentially subjecting patients to interventions that may diminish their remaining quality of life without meaningful survival benefit.

From a methodological standpoint, patients’ preferences were ascertained through validated survey instruments designed to capture nuanced perspectives on treatment goals, such as the dichotomy between comfort-oriented and life-prolonging care. The analysis compared mortality outcomes over a two-year period, stratified by whether patients received care aligned with their preferences. Surprisingly, the survival rates did not significantly differ between those receiving concordant comfort care and those undergoing discordant life-extending treatments, underscoring that aggressive therapies might not confer the intended longevity advantages in this subset.

The implications of these findings are profound. They suggest that life-extending treatments may be administered without clear evidence of benefit for patients who explicitly seek to avoid them, potentially exposing individuals to unnecessary side effects, hospitalizations, and decreased autonomy. This phenomenon also underscores systemic gaps in clinician-patient communication, shared decision-making processes, and possibly ingrained cultural biases favoring intervention over palliation.

Dr. Shah emphasizes the ethical imperative for oncologists and palliative care specialists to engage in transparent, iterative conversations with their patients. Such dialogues should elicit patients’ values, clarify the realistic outcomes of proposed treatments, and reconcile potential misunderstandings or therapeutic misalignments. This patient-centered approach is essential to uphold the principle of autonomy and ensure that care plans correspond to the patients’ own objectives, whether they prioritize longevity, comfort, or a balance of both.

The research also highlights the critical role of advance care planning, a process often underutilized or initiated too late in the disease trajectory, limiting its effectiveness. Early and structured discussions regarding prognosis, treatment options, and anticipated quality of life can provide a framework for care decisions that respect patients’ wishes and reduce the incidence of discordant treatments. Moreover, the integration of interdisciplinary teams, including palliative care specialists, social workers, and ethicists, may enhance the quality and alignment of care.

An intriguing aspect of the study is the comparison between patients with advanced cancer and those with other serious illnesses, such as heart failure or chronic obstructive pulmonary disease. While preferences for comfort-focused care were similarly distributed across these populations, patients with cancer were disproportionately more likely to experience discordant life-extending interventions. This differential may reflect disease-specific factors, oncologists’ treatment paradigms, or systemic pressures unique to oncology practice, pointing to the need for disease-tailored strategies to improve care concordance.

The findings challenge entrenched assumptions that more intervention equates to better care or improved survival. Instead, they call for a paradigm shift towards nuanced, individualized treatment plans that prioritize the patient’s lived experience and holistic well-being. Researchers advocate for enhanced training in communication skills for oncology clinicians and the development of decision aids that facilitate informed consent and goal-concordant care choices.

From a health systems perspective, reducing discordant care may also contribute to more sustainable resource utilization, mitigating the high costs associated with aggressive cancer treatments that do not extend life or improve quality. This approach aligns with broader trends emphasizing value-based care and ethical stewardship of medical interventions.

In conclusion, this study elucidates a critical gap in oncology care—the divergence between patients’ stated goals and the treatments they receive. Bridging this gap demands systematic improvements in patient-clinician communication, earlier advance care planning, and heightened awareness of the limitations and burdens of life-extending therapies in the context of advanced cancer. By realigning treatment intent with patient preferences, the oncology community can better honor individual values and improve end-of-life care experiences.

Subject of Research: Patient-reported discordance between care goals and treatment intent in advanced cancer

Article Title: Patient-reported discordance between care goals and treatment intent in advanced cancer

News Publication Date: 25-Aug-2025

Web References:

• CANCER Journal
• DOI Link

References:
Shah, M. P., Wenger, N. S., Glaspy, J., Hays, R. D., Sudore, R. L., Rahimi, M., Gibbs, L., Anand, S., Tseng, C.-H., & Walling, A. M. (2025). Patient-reported discordance between care goals and treatment intent in advanced cancer. CANCER. https://doi.org/10.1002/cncr.35976

Keywords: Cancer patients, health care delivery, patient preferences, advanced cancer, comfort-focused care, life-extending treatment, oncology, advance care planning, patient autonomy, end-of-life care, palliative care, medical ethics